Tenx Biopharma Inc is categorized under Drugs, Proprietaries, and Sundries in Philadelphia, PA and active since 2010.
Tenx Biopharma Inc was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Gardiner Smith at the company’s single location by writing to 1500 Jf Kennedy Boulevard # 1301, Philadelphia, Pennsylvania PA 19102 or by phoning (812) 218-8926. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tenx Biopharma Inc |
| Contact Person: | Gardiner Smith |
| Address: | 1500 Jf Kennedy Boulevard # 1301, Philadelphia, Pennsylvania 19102 |
| Phone Number: | (812) 218-8926 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Tenx Biopharma Inc was started in 2010 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Gardiner Smith for inquiries that concern Tenx Biopharma Inc by calling the company number (812) 218-8926, as your correspondence is most welcome. Additionally, the physical location of the single location of Tenx Biopharma Inc can be found at the coordinates 40.01735,-75.06936 as well as the street address 1500 Jf Kennedy Boulevard # 1301 in Philadelphia, Pennsylvania 19102.
For its online presence, you may visit Tenx Biopharma Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.